🎉 Orders $200+ Get Free Domestic Shipping!

Semaglutide

Semaglutide is a GLP-1 receptor agonist developed as a research compound for the study of metabolic function, appetite regulation, and insulin sensitivity. It mimics the action of the endogenous incretin hormone GLP-1 but has been chemically modified for enhanced stability and prolonged activity.

In research environments, Semaglutide has demonstrated potent effects in lowering blood glucose levels, promoting satiety, and reducing body weight. These results have made it a key compound in studies on obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). It is also being explored for its potential neuroprotective properties in neurological and cognitive disorders.

Semaglutide operates through a well-characterized mechanism of enhancing insulin secretion and slowing gastric emptying, and has shown systemic benefits across multiple organ systems. Although approved for therapeutic use in some regulated clinical settings, this product is sold strictly for in-vitro research purposes and is not approved for human or veterinary use.

Peptides will arrive in a lyophilized (powder) form for maximum stability

$119.97

Quantity

⚠️ Legal Disclaimer

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro laboratory research only. In-vitro studies (Latin: “in glass”) are performed outside of living organisms. These products are not medicines or drugs, and they have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. Under no circumstances should these products be introduced into the human or animal body, whether by injection, ingestion, topical application, or any other route. Bodily introduction is strictly prohibited by law.

Subscribe to our newsletter

Want to get 15% OFF site-wide plus a FREE keychain? Subscribe to our newsletter to claim this offer!

Please wait...

Thank you for subscribing!